Skaana Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
5,000
﹤0.01% 185
2026
Q1
$0 Hold
5,000
﹤0.01% 191
2025
Q4
$0 Hold
5,000
﹤0.01% 188
2025
Q3
$0 Hold
5,000
﹤0.01% 176
2025
Q2
$0 Hold
5,000
﹤0.01% 167
2025
Q1
$0 Hold
5,000
﹤0.01% 184
2024
Q4
$0 Hold
5,000
﹤0.01% 185
2024
Q3
$0 Hold
5,000
﹤0.01% 177
2024
Q2
$0 Hold
5,000
﹤0.01% 196
2024
Q1
$0 Hold
5,000
﹤0.01% 227
2023
Q4
$0 Hold
5,000
﹤0.01% 221
2023
Q3
$0 Buy
+5,000
New +$73 ﹤0.01% 228

Skaana Management's GRNAW Position: Q2 2026 in Review

Skaana Management held its GreenLight Biosciences Holdings, PBC Warrant (GRNAW) position steady in Q2 2026 at 5,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Skaana Management first reported a position in GRNAW in Q3 2023 and has held it in 12 quarters since. 1 fund tracked by Wall St. Rank holds GRNAW as of Q2 2026.

  • Skaana Management held 5,000 shares of GreenLight Biosciences Holdings, PBC Warrant worth $0 as of Q2 2026.
  • Skaana Management left its GreenLight Biosciences Holdings, PBC Warrant share count unchanged in Q2 2026.
  • GreenLight Biosciences Holdings, PBC Warrant made up ﹤0.01% of Skaana Management's portfolio in Q2 2026, its #185 holding.
  • Skaana Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2023 and has held it in 12 quarters since.
  • 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2026.

Based on Skaana Management's 13F filing for Q2 2026, filed 14 Aug 2026.